Germany· DE-A57-64df960055ed09df
Intratect
A medicinal product containing human normal immunoglobulin, registered in Germany by Biotest Pharma Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Human Normal Immunoglobulin
- Manufacturer
- Biotest Pharma Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- September 30, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Human normal immunoglobulin in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumCutaquig 165 mg/mlOctapharma Benelux
- United StatesAlygloGC Biopharma Corp.
- SpainBERIGLOBINA PCsl Behring S.A.
- FinlandCutaquigOctapharma AB
- SwedenBeriglobin 160 mg/ml Injektionsvätska, lösning i förfylld sprutaCSL Behring GmbH
- CzechiaGAMMANORMOctapharma (IP) SPRL, Brusel
- JapanｐＨ４処理酸性人免疫グロブリン（皮下注射）武田薬品工業
- IcelandCutaquigOctapharma AB
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Cutaquig, Cuvitru
- Belgium · Cutaquig, Cuvitru
- Bulgaria · Имуновенин, Интратект
- Cyprus · Gamunex, Intratect
- Czechia · Cutaquig, Cuvitru
- Denmark · Cutaquig, Cuvitru
- Estonia · Cutaquig, Gammanorm
- Spain · Cutaquig, Cuvitru
- Finland · Cutaquig, Cuvitru
- France · Clairyg, Cutaquig
- United Kingdom (Northern Ireland) · Cutaquig, Cuvitru
- Greece · Gaminex, Ig Vena
- Croatia · Cutaquig, Ig Vena
- Hungary · Cutaquig, Gammanorm
- Ireland · Cutaquig, Cuvitru
- Iceland · Cutaquig, Deqsiga
- Italy · Cutaquig, Cuvitru
- Liechtenstein · Deqsiga, Flebogamma Dif
- Lithuania · Cutaquig, Gammanorm
- Luxembourg · Cutaquig, Gammagard S/D (Solvent/Detergent)
- Latvia · Cutaquig, Gammanorm
- Malta · Cutaquig, Gammanorm
- Netherlands · Cutaquig, Cuvitru
- Norway · Cutaquig, Cuvitru
- Poland · Cutaquig, Cuvitru
- Portugal · Cutaquig, Gammanorm
- Romania · Cutaquig, Gammanorm
- Sweden · Cutaquig, Cuvitru
- Slovenia · Cutaquig, Gammanorm
- Slovakia · Cutaquig, Cuvitru
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dbdd6e8f-f094-4ead-9794-9e01ba0cc2ac GET /v1/drugs/dbdd6e8f-f094-4ead-9794-9e01ba0cc2ac?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Human Normal Immunoglobulin",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about human normal immunoglobulin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.